Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors.
Maria Cristina Ferreira de SousaInstitute of Parasitology, Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, 3012 Bern, Switzerland.
Joachim MüllerInstitute of Parasitology, Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, 3012 Bern, Switzerland.
Kai Pascal Alexander HänggeliInstitute of Parasitology, Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, 3012 Bern, Switzerland.
Manfred HellerDepartment for BioMedical Research (DBMR), Proteomics and Mass Spectrometry Core Facility, University of Bern, 3012 Bern, Switzerland.ORCID 0000-0002-6364-7325
Anne-Christine UldryDepartment for BioMedical Research (DBMR), Proteomics and Mass Spectrometry Core Facility, University of Bern, 3012 Bern, Switzerland.ORCID 0000-0003-2820-0277
Sophie Braga-LagacheDepartment for BioMedical Research (DBMR), Proteomics and Mass Spectrometry Core Facility, University of Bern, 3012 Bern, Switzerland.
Alexandre LeitaoCIISA-Centre for Interdisciplinary Research in Animal Health, Faculty of Veterinary Medicine, University of Lisbon, 1300-477 Lisbon, Portugal.ORCID 0000-0002-8398-6754
Luis-Miguel Ortega-MoraSaluvet, Animal Health Department, Faculty of Veterinary Sciences, Complutense University of Madrid, Ciudad Universitaria S/N, 28040 Madrid, Spain.ORCID 0000-0002-4986-6783
Kayode K OjoDepartment of Medicine, Center for Emerging and Re-Emerging Infectious Diseases, University of Washington, Seattle, WA 98109-4766, USA.ORCID 0000-0002-2007-2170
Wesley C Van VoorhisDepartment of Medicine, Center for Emerging and Re-Emerging Infectious Diseases, University of Washington, Seattle, WA 98109-4766, USA.ORCID 0000-0001-6141-2015
Andrew HemphillInstitute of Parasitology, Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, 3012 Bern, Switzerland.ORCID 0000-0002-0622-2128
Funding
NIH Common Fund R01HD102487 R01AI55412Swiss Government Excellence Fellowship MSCSwiss National Science Foundation 310030_214897Uniscientia Foundation Toxo
6 · The paper itself
Abstract
Bumped kinase inhibitors (BKIs) have demonstrated safety and promising efficacy against various apicomplexan pathogens both in vitro and in vivo, but do not act parasiticidal in vitro. In the closely related cyst-forming coccidians
Indexed as
CytokinesisNeosporaProtein Kinase InhibitorsPyrimidinesSarcocystidaeToxoplasmaAnimalsCoccidiosisProteomicsProtozoan ProteinsProtein Kinase InhibitorsProtozoan ProteinsPyrimidinesapicomplexan parasitesbaryzoitesbumped kinase inhibitorcalcium dependent protein kinasecoccidiamitogen activated protein kinase-like 1multinucleated complexesproteomics
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Bumped Kinase Inhibitor BKI-1708 Interferes in Cytokinesis and Drives Baryzoite Conversion in the Cyst-Forming Apicomplexan Parasites · full record | Socratic